Find Icosapent Ethyl manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

EU WC

EU WC

0

NDC API

NDC API

0

VMF

NDC API

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

USP

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

89RELATED EXCIPIENT COMPANIES

151EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Exclusivities

API REF. PRICE (USD/KG)

GLOBAL SALES INFORMATION

Annual Reports

NA

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

0

FDF

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Timnodonic acid, Icosapent, 10417-94-4, Icosapentaenoic acid, Epa, Cis-5,8,11,14,17-eicosapentaenoic acid
Molecular Formula
C20H30O2
Molecular Weight
302.5  g/mol
InChI Key
JAZBEHYOTPTENJ-JLNKQSITSA-N
FDA UNII
AAN7QOV9EA

Icosapent Ethyl
Important polyunsaturated fatty acid found in fish oils. It serves as the precursor for the prostaglandin-3 and thromboxane-3 families. A diet rich in eicosapentaenoic acid lowers serum lipid concentration, reduces incidence of cardiovascular disorders, prevents platelet aggregation, and inhibits arachidonic acid conversion into the thromboxane-2 and prostaglandin-2 families.
1 2D Structure

Icosapent Ethyl

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoic acid
2.1.2 InChI
InChI=1S/C20H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h3-4,6-7,9-10,12-13,15-16H,2,5,8,11,14,17-19H2,1H3,(H,21,22)/b4-3-,7-6-,10-9-,13-12-,16-15-
2.1.3 InChI Key
JAZBEHYOTPTENJ-JLNKQSITSA-N
2.1.4 Canonical SMILES
CCC=CCC=CCC=CCC=CCC=CCCCC(=O)O
2.1.5 Isomeric SMILES
CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O
2.2 Other Identifiers
2.2.1 UNII
AAN7QOV9EA
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 5,8,11,14,17-eicosapentaenoic Acid

2. 5,8,11,14,17-icosapentaenoic Acid

3. Acid, Eicosapentanoic

4. Eicosapentanoic Acid

5. Icosapent

6. Omega 3 Eicosapentaenoic Acid

7. Omega-3-eicosapentaenoic Acid

8. Timnodonic Acid

2.3.2 Depositor-Supplied Synonyms

1. Timnodonic Acid

2. Icosapent

3. 10417-94-4

4. Icosapentaenoic Acid

5. Epa

6. Cis-5,8,11,14,17-eicosapentaenoic Acid

7. (5z,8z,11z,14z,17z)-icosa-5,8,11,14,17-pentaenoic Acid

8. Icosapento

9. Icosapentum

10. 5,8,11,14,17-eicosapentaenoic Acid

11. Eicosapentaenoate

12. 5z,8z,11z,14z,17z-eicosapentaenoic Acid

13. (all-z)-5,8,11,14,17-eicosapentaenoic Acid

14. Icosapent [inn]

15. (5z,8z,11z,14z,17z)-5,8,11,14,17-eicosapentaenoic Acid

16. 5,8,11,14,17-icosapentaenoic Acid

17. Ropufa 70

18. Ccris 3279

19. Incromega E 7010sr

20. Aan7qov9ea

21. (5z,8z,11z,14z,17z)-icosapentaenoic Acid

22. (5z,8z,11z,14z,17z)-eicosapentaenoic Acid

23. Omega-3-carboxylic Acids

24. Epa 45g

25. Chembl460026

26. (5z,8z,11z,14z,17z)-eicosapentaenoate

27. All-cis-5,8,11,14,17-icosapentaenoic Acid

28. Chebi:28364

29. All-cis-5,8,11,14,17-eicosapentaenoic Acid

30. All-cis-icosa-5,8,11,14,17-pentaenoic Acid

31. Icosapent (inn)

32. Cis-delta(5,8,11,14,17)-eicosapentaenoic Acid

33. 5,8,11,14,17-eicosapentaenoic Acid, (all-z)-

34. All-cis-fatty Acid 20:5 Omega-3

35. Eicosapentaenoic Acid (c20:5 N3)

36. Epa;timnodonic Acid

37. Icosapentaenoate

38. (all-z)-delta5,8,11,14,17-eicosapentaenoic Acid

39. C20:5n-3,6,9,12,15

40. Cis-5,8,11,14,17-epa

41. Fa 20:5

42. Ncgc00161344-03

43. C20:5 (n-3)

44. Eicosapentaenoic Acid (20:5 N-3)

45. Eicosa-5z,8z,11z,14z,17z-pentaenoic Acid (20:5, N-3)

46. Miraxion

47. Eicosapentanoic Acid

48. Eye Q

49. Eye-q

50. 5,8,11,14,17-eicosapentaenoic Acid, (5z,8z,11z,14z,17z)-

51. Epa [drug]

52. Unii-aan7qov9ea

53. 1553-41-9

54. Icosapentum [inn-latin]

55. Icosapento [inn-spanish]

56. (5z,8z,11z,14z,17z)-icosapentaenoate

57. Timnodonate

58. 3gwx

59. All Cis-5,8,11,14,17-eicosapentaenoic Acid

60. Mfcd00065716

61. All-cis-icosapentaenoate

62. All-cis-icosapentaenoic Acid

63. Dsstox_cid_21023

64. Dsstox_rid_79612

65. Dsstox_gsid_41023

66. Schembl20469

67. Bspbio_001328

68. Bml3-b01

69. Gtpl3362

70. Dtxsid9041023

71. Eicosapentaenoic Acid [mi]

72. Hms1361c10

73. Hms1791c10

74. Hms1989c10

75. Hms3402c10

76. Hms3649d19

77. Hy-b0660

78. Zinc4474603

79. 5,8,11,14,17-icosapentaenoate

80. Eicosapentaenoic Acid [inci]

81. Tox21_111991

82. 5,8,11,14,17-eicosapentaenoate

83. Bdbm50242349

84. Eicosapentaenoic Acid [vandf]

85. Lmfa01030759

86. S6476

87. Eicosapentaenoic Acid [mart.]

88. Akos027470327

89. Eicosapentaenoic Acid [usp-rs]

90. Eicosapentaenoic Acid [who-dd]

91. Ccg-207957

92. Ccg-208136

93. Db00159

94. Cis-5,8,11,14,17-eicosapentaenoate

95. Idi1_033798

96. Ncgc00161344-01

97. Ncgc00161344-02

98. Ncgc00161344-04

99. Ncgc00161344-07

100. 5z,8z,11z,14z,17z-eicosapentaenoate

101. Ac-31072

102. As-53730

103. Cas-10417-94-4

104. E0441

105. 5,8,11,14,17-eicosapentaenoic Acid (6ci)

106. All Cis-5,8,11,14,17-icosapentaenoic Acid

107. C06428

108. D08061

109. P16966

110. (all-cis)-5,8,11,14,17-eicosapentaenoic Acid

111. Eicosapentaenoic Acid (epa) (c20:5 N3)

112. L001256

113. Q409990

114. Sr-01000946647

115. Fa(20:5(5z,8z,11z,14z,17z))

116. J-001125

117. Sr-01000946647-1

118. Z,z,z,z,z-eicosa-5,8,11,14,17-pentaenoic Acid

119. (z,z,z,z,z)-5,8,11,14,17-eicosapentaenoic Acid

120. Brd-k47192521-001-02-1

121. Cis-5,8,11,14,17-eicosapentaenoic Acid, >=99%

122. 7f8bf016-b146-4f72-a52e-b9298ba3a9ab

123. C20h30o2 (cis-5,8,11,14,17-eicosapentaenoic Acid)

124. Eicosapentaenoic Acid, 5,8,11,14,17-(z,z,z,z,z)-

125. 5,8,11,14,17-eicosapentaenoic Acid, (all-z)- (8ci)

126. Cis-5,8,11,14,17-eicosapentaenoic Acid, >=85%, Liquid

127. Cis-5,8,11,14,17-eicosapentaenoic Acid, Analytical Standard

128. (5z,8z,11 Z,14z,17z)-icosa-5,8,11,14,17-pentaenoic Acid

129. (5z,8z,11z,14z,17z)-eicosa-5,8,11,14,17-pentaenoic Acid

130. Cis, Cis, Cis, Cis, Cis-eicosa-5,8,11,14,17-pentaenoic Acid

131. 5,8,11,14,17-eicosapentaenoic Acid, (5z,8z,11z,14z,17z)- (9ci)

132. Eicosapentaenoic Acid (epa) (c20:5) (constituent Of Krill Oil) [dsc]

133. Cis-5,8,11,14,17-eicosapentaenoic Acid, 500 Mug/ml In Ethanol, Certified Reference Material

2.4 Create Date
2005-03-26
3 Chemical and Physical Properties
Molecular Weight 302.5 g/mol
Molecular Formula C20H30O2
XLogP35.6
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count2
Rotatable Bond Count13
Exact Mass302.224580195 g/mol
Monoisotopic Mass302.224580195 g/mol
Topological Polar Surface Area37.3 Ų
Heavy Atom Count22
Formal Charge0
Complexity398
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count5
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

EPA can be used for lowering elevated triglycerides in those who are hyperglyceridemic. In addition, EPA may play a therapeutic role in patients with cystic fibrosis by reducing disease severity and may play a similar role in type 2 diabetics in slowing the progression of diabetic nephropathy.


FDA Label


OM3-CA is indicated as an adjunct to diet to reduce triglycerides levels in adults patients with severe hypertriglyceridemia (>500 mg/dL). The patients involved in this treatment should be laced with an appropriate lipid-lowering diet. Hypertriglyceridemia is defined as an elevated plasma triglyceride concentration. It is usually correlated to other secondary conditions such as poor diet, alcohol use, obesity, metabolic syndrome and type 2 diabetes.


FDA Label


Treatment of Familial Adenomatous Polyposis


Treatment of dyslipidaemia


5 Pharmacology and Biochemistry
5.1 Pharmacology

Eicosanoids are chemical messengers derived from 20-carbon polyunsaturated fatty acids that play critical roles in immune and inflammatory responses. Both 20-carbon omega-6 fatty acids (arachidonic acid) and 20-carbon omega-3 fatty acids (EPA) can be found in cell membranes. During an inflammatory response, arachidonic acid and EPA are metabolized by enzymes known as cyclooxygenases and lipoxygenases to form eicosanoids. Increasing omega-3 fatty acid intake increases the EPA content of cell membranes and decreases the arachidonic acid content, resulting in higher proportions of eicosanoids derived from EPA. Physiologic responses to arachidonic acid-derived eicosanoids differ from responses to EPA-derived eicosanoids. In general, eicosanoids derived from EPA are less potent inducers of inflammation, blood vessel constriction, and clotting than eicosanoids derived from arachidonic acid.


OM3-CA is very effective in reducing triglyceride levels. After 14 days of treatment, it is possible to observe even a 21% reduction. The reduction of the triglycerides could reach even to 25% in cases with the maximal used concentration of 4 g.


5.2 Absorption, Distribution and Excretion

Absorption

When compared to omega-3 -acid ethyl esters, OM3-CA present a 4-fold higher bioavailability. OM3-CA is absorbed directly in the small intestine and the maximal plasma concentration is reached between 4.5-5 hours after initial administration. The absorbed dosage is transferred to the general circulation via the lymphatic system and distributed within tissues throughout the body. The absorption speed and extent is highly promoted by the bile. In preclinical studies performed in dogs, the Cmax, tmax and AUC were reported to be 15.1 mcg/ml, 24 hours and 1210.3 mcg.h/ml, respectively.


Route of Elimination

OM3-CA does not go under renal excretion. After the metabolism, all the dose is excreted as CO2 and water in the form of expelled air and the rest is excreted in feces.


Volume of Distribution

This pharmacokinetic property is not available.


Clearance

The registered clearance rate at steady-state is of 548 ml/h for eicosapentaenoic acid and 518 ml/h for docohexaenoic acid.


5.3 Metabolism/Metabolites

OM3-CA is metabolized in the liver following the normal fatty acid oxidation. Once absorbed, they are incorporated into triglycerides, cholesterol esters and phospholipids in tissues. The metabolism is marked by beta-oxidation followed by tricarboxylic acid cycle. It is reported that OM3-CA is an inhibitor of several enzymes such as CYP2C9, CYP2C19 and to a lesser extent to CYP1A2, CYP2E1, CYP3A4. It is thought that the metabolism of OM3-CA is mainly done by CYP3A and CYP4F3B.


Eicosapentaenoic acid has known human metabolites that include Juniperonic acid.

S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560


5.4 Biological Half-Life

The half-life of OM3-CA depends on the type of component in which for eicosapentaenoic acid it is estimated to be of approximately 4.7-10.8 hours while for docosahexaenoic acid is reported to be of about 7 hours. The half-life of baseline-adjusted at steady-state is of 36 and 46 hours respectively for eicosapentaenoic acid and docosahexaenoic acid.


5.5 Mechanism of Action

The anti-inflammatory, antithrombotic and immunomodulatory actions of EPA is probably due to its role in eicosanoid physiology and biochemistry. Most eicosanoids are produced by the metabolism of omega-3 fatty acids, specifically, arachidonic acid. These eicosanoids, leukotriene B4 (LTB4) and thromboxane A2 (TXA2) stimulate leukocyte chemotaxis, platelet aggregation and vasoconstriction. They are thrombogenic and artherogenic. On the other hand, EPA is metabolized to leukotriene B5 (LTB5) and thromboxane A3 (TXA3), which are eicosanoids that promote vasodilation, inhibit platelet aggregation and leukocyte chemotaxis and are anti-artherogenic and anti-thrombotic. The triglyceride-lowering effect of EPA results from inhibition of lipogenesis and stimulation of fatty acid oxidation. Fatty acid oxidation of EPA occurs mainly in the mitochondria. EPA is a substrate for Prostaglandin-endoperoxide synthase 1 and 2. It also appears to affect the function and bind to the Carbohydrate responsive element binding protein (ChREBP) and to a fatty acid receptor (G-coupled receptor) known as GP40.


The reduction of the synthesis of triglycerides in the liver may be caused because the main components of OM3-CA, eicosapentaenoic acid, and docosahexaenoic acid, are poor substrates for the enzymes responsible for the synthesis of triglycerides. These two major components inhibit the esterification of other fatty acids. OM3-CA is also thought to enhance the clearance of triglycerides from the circulating very low-density lipoprotein particles by different potential effects such as inhibition of acyl-CoA:1,2-diacylglycerol acyltransferase, increase in mitochondrial and peroxisomal beta-oxidation in the liver, decrease lipogenesis in the liver and increase lipoprotein lipase activity.


USDMF

read-more
read-moreread-more

01

Finorga Sas

Germany
arrow
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAxplora is your partner of choice for complex APIs.

Flag Germany
Digital Content Digital Content

GDUFA

DMF Review : Complete

Rev. Date : 2023-06-07

Pay. Date : 2023-06-05

DMF Number : 27182

Submission : 2013-05-23

Status : Active

Type : II

Axplora CB

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothChunghwa provides cost-effective APIs & advanced intermediates with complete DMF or COS, ensuring quality & reliable production.

Flag Taiwan
Digital Content Digital Content

GDUFA

DMF Review : Complete

Rev. Date : 2013-04-01

Pay. Date : 2012-11-20

DMF Number : 26271

Submission : 2012-08-01

Status : Active

Type : II

CCSB Company Banner

03

Ak Biopharm Co Ltd

South Korea

USDMF

arrow
DDL Conference
Not Confirmed

03

Ak Biopharm Co Ltd

South Korea
arrow
DDL Conference
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 26946

Submission : 2013-03-04

Status : Active

Type : II

blank

04

Ak And Mn Biofarm Co Ltd

South Korea

USDMF

arrow
DDL Conference
Not Confirmed

04

DDL Conference
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 27998

Submission : 2014-02-10

Status : Active

Type : II

blank

05

Basf As

Germany

USDMF

arrow
DDL Conference
Not Confirmed

05

Basf As

Germany
arrow
DDL Conference
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2020-11-02

Pay. Date : 2020-10-20

DMF Number : 23911

Submission : 2010-07-07

Status : Active

Type : II

blank

06

DDL Conference
Not Confirmed

06

DDL Conference
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 25289

Submission : 2011-09-12

Status : Inactive

Type : II

blank

07

Chemport Inc

United Kingdom

USDMF

arrow
DDL Conference
Not Confirmed

07

Chemport Inc

United Kingdom
arrow
DDL Conference
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 22077

Submission : 2008-10-09

Status : Inactive

Type : II

blank

08

Kd Pharma Bexbach Gmbh

Germany

USDMF

arrow
DDL Conference
Not Confirmed

08

DDL Conference
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2015-02-20

Pay. Date : 2014-04-09

DMF Number : 28140

Submission : 2014-03-31

Status : Active

Type : II

blank

09

Kd Pharma Bexbach Gmbh

Germany

USDMF

arrow
DDL Conference
Not Confirmed

09

DDL Conference
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2013-08-21

Pay. Date : 2013-02-27

DMF Number : 26892

Submission : 2013-02-26

Status : Active

Type : II

blank

10

Nissui Corporation

Japan

USDMF

arrow
DDL Conference
Not Confirmed

10

DDL Conference
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 22474

Submission : 2009-01-23

Status : Active

Type : II

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

JDMF

read-more
read-moreread-more

01

DDL Conference
Not Confirmed
arrow
arrow
DDL Conference
Not Confirmed

AK&MN Biofarm Eicosapentate (raw material) (for export)

Registration Number : 227MF10010

Registrant's Address : #81, Sanggae-Ro, Nam-Gu, Ulsan, Korea

Initial Date of Registration : 2015-01-05

Latest Date of Registration : 2015-01-05

blank

02

DDL Conference
Not Confirmed
arrow
arrow
DDL Conference
Not Confirmed

Maxomega EPA97EE

Registration Number : 223MF10118

Registrant's Address : 4th and 5th Floors, 2 Stockport Exchange, Railway Road, Stockport, SK1 3GG, UK

Initial Date of Registration : 2011-07-25

Latest Date of Registration : 2025-09-11

blank

03

DDL Conference
Not Confirmed
arrow
arrow
DDL Conference
Not Confirmed

Icosapentosan EQ

Registration Number : 217MF10441

Registrant's Address : 363 Tokutomi, Akaiwa City, Okayama Prefecture

Initial Date of Registration : 2005-08-19

Latest Date of Registration : 2020-06-11

blank

04

Chemport Inc.

United Kingdom
DDL Conference
Not Confirmed
arrow

Chemport Inc.

United Kingdom
arrow
DDL Conference
Not Confirmed

Ethyl icosapentate

Registration Number : 227MF10158

Registrant's Address : 30-5 Dongsunonggongdanji-gil, Naju-si, Jeollanam-do 58275, Korea

Initial Date of Registration : 2015-06-18

Latest Date of Registration : 2016-07-15

blank

05

DDL Conference
Not Confirmed
arrow
arrow
DDL Conference
Not Confirmed

Ethyl icosapentate

Registration Number : 303MF10106

Registrant's Address : No. 37 Section 6, North Chengdu Avenue, Guanghan, Deyang City, Sichuan Province P. R....

Initial Date of Registration : 2021-07-09

Latest Date of Registration : 2023-08-09

blank

06

DDL Conference
Not Confirmed
arrow
arrow
DDL Conference
Not Confirmed

Ethyl icosapentate

Registration Number : 228MF10081

Registrant's Address : Am Kraftwerk 6,66450 Bexbach, Germany

Initial Date of Registration : 2016-04-06

Latest Date of Registration : 2016-04-06

blank

07

DDL Conference
Not Confirmed
arrow
arrow
DDL Conference
Not Confirmed

Ethyl icosapentate

Registration Number : 303MF10048

Registrant's Address : Am Kraftwerk 6,66450 Bexbach, Germany

Initial Date of Registration : 2021-03-17

Latest Date of Registration : 2021-03-17

blank

08

DDL Conference
Not Confirmed
arrow
arrow
DDL Conference
Not Confirmed

EPA-E "Nissin"

Registration Number : 217MF11111

Registrant's Address : 1-25 Kanda Nishikicho, Chiyoda-ku, Tokyo

Initial Date of Registration : 2005-12-05

Latest Date of Registration : 2023-09-13

blank

09

DDL Conference
Not Confirmed
arrow
arrow
DDL Conference
Not Confirmed

ETHYL ICO SAPENTATE

Registration Number : 305MF10044

Registrant's Address : No. 1, Lutai Road, High-tech District, Zibo, Shandong, P. R. China

Initial Date of Registration : 2023-04-05

Latest Date of Registration : 2023-04-05

blank

10

DDL Conference
Not Confirmed
arrow
arrow
DDL Conference
Not Confirmed

EPA-E Tama

Registration Number : 217MF10180

Registrant's Address : 1-23-3 Nishi-Shinjuku, Shinjuku-ku, Tokyo

Initial Date of Registration : 2005-06-06

Latest Date of Registration : 2007-03-05

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

KDMF

read-more
read-moreread-more

01

AK BIOPHARM

South Korea
Saudi International Expo
Not Confirmed
arrow

AK BIOPHARM

South Korea
arrow
Saudi International Expo
Not Confirmed

Ethyl icosapentaenoic acid

Registrant Name : Aekyung Biopharm Co., Ltd.

Registration Date : 2024-06-28

Registration Number : 20240628-211-J-1661

Manufacturer Name : Aekyung Biopharm Co., Ltd.

Manufacturer Address : 81 Sanggae-ro, Nam-gu, Ulsan Metropolitan City (80, 80A)

blank

02

Chemport Inc

United Kingdom
Saudi International Expo
Not Confirmed
arrow

Chemport Inc

United Kingdom
arrow
Saudi International Expo
Not Confirmed

Ethyl icosapentate

Registrant Name : Kemport Co., Ltd.

Registration Date : 2022-08-22

Registration Number : 20220822-211-J-1348

Manufacturer Name : Kemport Co., Ltd.

Manufacturer Address : Laboratory: 2nd floor, Research Building, 52, Goha-daero 719beongil, Mokpo-si, Jeolla...

blank

03

KD Pharma Group

Switzerland
Saudi International Expo
Not Confirmed
arrow

KD Pharma Group

Switzerland
arrow
Saudi International Expo
Not Confirmed

Ethyl icosapentaenoic acid

Registrant Name : Aging Life Science Co., Ltd.

Registration Date : 2024-02-23

Registration Number : 20240223-211-J-1613

Manufacturer Name : KD Pharma Bexbach GmbH @ KD ...

Manufacturer Address : Am Kraftwerk 6 - 8 66450 Bexbach Germany@Fabrikstraße 51 66424 Homburg Germany

blank

04

Saudi International Expo
Not Confirmed
arrow
arrow
Saudi International Expo
Not Confirmed

Ethyl icosapentaenoic acid

Registrant Name : Mpeak Korea Co., Ltd.

Registration Date : 2025-04-15

Registration Number : 20250415-211-J-1850

Manufacturer Name : Shandong Xinhua Pharmaceutic...

Manufacturer Address : Hutian Chemical Industrial Zone, Zibo, Shandong, China

blank

05

Saudi International Expo
Not Confirmed
arrow
arrow
Saudi International Expo
Not Confirmed

Ethyl icosapentaenoic acid

Registrant Name : Ace Biopharm Co., Ltd.

Registration Date : 2025-04-21

Registration Number : 20250421-211-J-1869

Manufacturer Name : Zhejiang Medicine Co., Ltd. ...

Manufacturer Address : 98 East Xinchang Dadao Road, Xinchang, Zhejiang, PR China,312500

blank

06

Saudi International Expo
Not Confirmed
arrow

arrow
Saudi International Expo
Not Confirmed

Ethyl icosapentaenoic acid

Registrant Name : VON Bio Co., Ltd.

Registration Date : 2025-11-04

Registration Number : 20251104-211-J-2032

Manufacturer Name : Nissui Corporation, Kashima ...

Manufacturer Address : 18-2, HigashiFukashiba, Kamis, Ibaraki 314-0103, Japan

blank

07

Saudi International Expo
Not Confirmed
arrow

arrow
Saudi International Expo
Not Confirmed

Ethyl icosapentaenoic acid

Registrant Name : VON Bio Co., Ltd.

Registration Date : 2025-11-04

Registration Number : 20251104-211-J-2033

Manufacturer Name : Nissui Corporation, Tsukuba ...

Manufacturer Address : 7, Okubo, Tsukuba-shi, Ibaraki 300-2611, Japan

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

Axplora

Germany
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAxplora is your partner of choice for complex APIs.

Flag Germany
Digital Content Digital Content

Icosapent Ethyl

About the Company : Axplora, created from the merger of Farmabios, Novasep & PharmaZell, is a leading API manufacturing partner to the world’s leading pharma & biotech companies, delivering top-qual...

Axplora, created from the merger of Farmabios, Novasep & PharmaZell, is a leading API manufacturing partner to the world’s leading pharma & biotech companies, delivering top-quality APIs on time & at scale, to the highest industry standards. It is dedicated to helping pharma companies make critical medicines safely to benefit patients. Leveraging our combined expertise & manufacturing capabilities across 9 industrial sites in the EU & India & an R&D facility in the USA, it offers CDMO services for small molecule APIs & biopharmaceuticals to innovators as well as APIs that address lifestyle-induced respiratory, inflammatory & liver diseases.
Axplora CB

02

DKSH

Switzerland
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDKSH is your trusted partner for companies looking to grow their business in Asia & beyond.

Flag Switzerland
Digital Content Digital Content

Icosapent Ethyl

About the Company : DKSH, founded with the goal of improving people's lives, assists businesses with market expansion and business growth in both existing and emerging markets. It has been fostering g...

DKSH, founded with the goal of improving people's lives, assists businesses with market expansion and business growth in both existing and emerging markets. It has been fostering growth for businesses in Asia and beyond for over 155 years. DKSH operates in 36 markets, is listed on the SIX Swiss Exchange, employs 33,100 specialists, and generated net sales of CHF 11.1 billion in 2021. It is the leading global distributor of innovative pharma ingredients for pharmaceutical synthesis and formulation. It offers a range of products, ranging from animal care products to packaging materials, intermediates to nutraceuticals, and APIs to excipients.
DKSH Company Banner

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothChunghwa provides cost-effective APIs & advanced intermediates with complete DMF or COS, ensuring quality & reliable production.

Flag Taiwan
Digital Content Digital Content

Icosapent Ethyl

About the Company : Chunghwa Chemical Synthesis & Biotech Co. Ltd. (CCSB) offers global customers cost-effective APIs with speed, supported by our well-trained staff. As the first company in Southeast...

Chunghwa Chemical Synthesis & Biotech Co. Ltd. (CCSB) offers global customers cost-effective APIs with speed, supported by our well-trained staff. As the first company in Southeast Asia to receive FDA approval for synthetic and biotech APIs, CCSB has a proven track record of commercializing Statin, Immunosuppressant, Muscle Relaxant, and ACE Inhibitor APIs, all with complete DMF or COS. For years, CCSB has partnered with leading brand and generic drug companies to develop and produce APIs and advanced intermediates, focusing on specialty APIs crafted through a sophisticated fusion of fermentation and synthesis technologies in Taiwan.
CCSB Company Banner

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothChunghwa provides cost-effective APIs & advanced intermediates with complete DMF or COS, ensuring quality & reliable production.

Flag Taiwan
Digital Content Digital Content

Eicosapentaenoic Acid

About the Company : Chunghwa Chemical Synthesis & Biotech Co. Ltd. (CCSB) offers global customers cost-effective APIs with speed, supported by our well-trained staff. As the first company in Southeast...

Chunghwa Chemical Synthesis & Biotech Co. Ltd. (CCSB) offers global customers cost-effective APIs with speed, supported by our well-trained staff. As the first company in Southeast Asia to receive FDA approval for synthetic and biotech APIs, CCSB has a proven track record of commercializing Statin, Immunosuppressant, Muscle Relaxant, and ACE Inhibitor APIs, all with complete DMF or COS. For years, CCSB has partnered with leading brand and generic drug companies to develop and produce APIs and advanced intermediates, focusing on specialty APIs crafted through a sophisticated fusion of fermentation and synthesis technologies in Taiwan.
CCSB Company Banner

05

BASF

Germany
DDL Conference
Not Confirmed
arrow

BASF

Germany
arrow
DDL Conference
Not Confirmed

EICOSAPENTAENOIC ACID ETHYL ESTER (EPA-E)

About the Company : We create chemistry for a sustainable future. In line with our corporate purpose, around 112,000 employees contribute to the success of our customers in nearly all sectors and alm...

We create chemistry for a sustainable future. In line with our corporate purpose, around 112,000 employees contribute to the success of our customers in nearly all sectors and almost every country in the world. Our broad portfolio ranges from chemicals, plastics, performance products and crop protection products to oil and gas. In 2015, BASF posted sales of €70 billion and income from operations before special items of approximately €6.7 billion. We combine economic success with environmental protection and social responsibility. Through research and innovation, we support our customers in nearly every industry.
blank

06

Royal DSM

Netherlands
DDL Conference
Not Confirmed
arrow

Royal DSM

Netherlands
arrow
DDL Conference
Not Confirmed

Icosapent Ethyl

About the Company : Royal DSM, founded in 1902, is a global, purpose-led health, nutrition, and bioscience company that specializes in human and animal health and nutrition solutions. Its primary goal...

Royal DSM, founded in 1902, is a global, purpose-led health, nutrition, and bioscience company that specializes in human and animal health and nutrition solutions. Its primary goal is to develop health and nutrition solutions that are scientifically sound. Royal DSM's products and solutions address some of the world's most pressing issues while also adding economic, environmental and societal value to all stakeholders. More than 2.5 billion people worldwide use the company's solutions. Royal DSM and its affiliated companies employ approximately 23,000 people worldwide and generate around €10 billion in net sales per year.
blank

07

DDL Conference
Not Confirmed
arrow
arrow
DDL Conference
Not Confirmed

Icosapent Ethyl

About the Company : Guowei Pharmaceutical was established in 2005 and is headquartered in Chengdu High-tech Zone. Its subsidiaries include Chengdu Guowei Biopharmaceutical Co., Ltd., Sichuan Guowei Ph...

Guowei Pharmaceutical was established in 2005 and is headquartered in Chengdu High-tech Zone. Its subsidiaries include Chengdu Guowei Biopharmaceutical Co., Ltd., Sichuan Guowei Pharmaceutical Co., Ltd., and Shanghai Ocuen Biotechnology Co., Ltd. After years of development, Guowei Pharmaceutical has developed into a comprehensive pharmaceutical enterprise integrating R&D, production, and sales. Guowei Pharmaceutical's research and development and sales of products are mainly concentrated in the fields of cardiovascular and cerebrovascular, digestive system, anti-infection, and urinary system.
blank

08

DDL Conference
Not Confirmed
arrow
arrow
DDL Conference
Not Confirmed

Icosapent Ethyl

About the Company : Zenfold Sustainable Technologies (ZST) is a specialty and fine chemicals company, established in 2021. Our advanced technological capabilities and state-of-the-art infrastructure a...

Zenfold Sustainable Technologies (ZST) is a specialty and fine chemicals company, established in 2021. Our advanced technological capabilities and state-of-the-art infrastructure allow us to provide the entire gamut of services involved in manufacturing and contract research — from process development to scaling up. We offer a wide range of APIs and intermediates to customers across industries. We differentiate ourselves in the market with our unique hybridized approach to manufacturing, built on our three core technological platforms: Synthetic Biology, Biotransformation, and Green Chemistry.
blank

09

DDL Conference
Not Confirmed
arrow
arrow
DDL Conference
Not Confirmed

Icosapent Ethyl

About the Company : Zhejiang Medicine Co., Ltd. is a large-scale joint-stock comprehensive pharmaceutical enterprise which was set up in May 1997. Being approved in August 1999 by the China Securities...

Zhejiang Medicine Co., Ltd. is a large-scale joint-stock comprehensive pharmaceutical enterprise which was set up in May 1997. Being approved in August 1999 by the China Securities Regulatory Commission, the company issued 58 million A shares to the public, and in October of the same year the company shares were listed on the Shanghai Securities Exchange. Up to the third quarter of 2013, the registered capital has reached CNY 930,000,000, and the total assets have reached CNY 7,300,000,000. Zhejiang Medicine Co. Ltd. owns five subsidiaries including Xinchang Pharmaceutical Factory, Vitamin Factory, Zhejiang Changhai Biological Co. Ltd., Zhejiang Health Creation Bio-technology Co. Ltd., and Zhejiang Health Creation Pharmaceutical Co. Ltd., and two R&D units including Research Institute of Pharmaceutical Industry and Shanghai Health Creation Bio-Pharmaceutical R&D Center. The company has been rated as "National High-tech Enterprise" and "National Innovative Enterprise", which owns state-level enterprise technology center and also has established a postdoctoral research station. There are more than 5000 employees, more than 2000 of which are professional technicians accounting for more than 40%. At present, Zhejiang Medicine Co. Ltd. is specialized in the large-scale production of fat-soluble vitamins, quasi-vitamins, quinolone antibiotics, anti-drug-resistant antibiotics and other products. Its output of vitamin E is the largest domestically, and the 2nd largest globally; the output of Vancomycin hydrochloride accounts for more than 40% of the global production; it is the largest vendor of β-carotene and canthaxanthin domestically, and the 3rd globally; the output of Coenzyme Q10 accounts for 20% of the global production. Through earnestly implementing the development strategy of " innovation, competition, science and technology as well as talent thriving are all critical in the development of the company", Zhejiang Medicine Co., Ltd. tightly holds the main line of product development, highlights the structure adjustment and integration of various resources, strengthens the original technological innovation and competitive product technology innovation, does well on DMF file registration and FDA certification for some competitive varieties, actively promotes clean production and circular economy, builds perfect market network by taking globalization as standpoint, establishes good brand image , building up advanced enterprise culture, and strongly promotes the core competitiveness. Currently, Zhejiang Medicine Co., Ltd. has become a large-scale pharmaceutical company with advanced technology, strong capital and technical strength which has an influence in the global market.
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

read-more
read-more
[{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1643221800,"product":"ICOSAPENT ETHYL EICOSAPENTAENOIC ACID ETHYL ESTER (MAXOMEGATM EPA 96EE)(100 KG\/10 KG PER BOTTLE. USD 35500)","address":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N","city":"HYDERABAD","supplier":"BASF CORP","supplierCountry":"UNITED KINGDOM","foreign_port":"#N\/A","customer":"DR REDDY'S LABORATORIES","customerCountry":"INDIA","quantity":"100.00","actualQuantity":"100","unit":"KGS","unitRateFc":"350","totalValueFC":"42260.3","currency":"USD","unitRateINR":"31481.2","date":"27-Jan-2022","totalValueINR":"3148117.72","totalValueInUsd":"42260.3","indian_port":"BANGALORE AIR","hs_no":"29163990","bill_no":"7250573","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"#N\/A","supplierAddress":"","customerAddress":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1643221800,"product":"ICOSAPENT ETHYL EICOSAPENTAENOIC ACID ETHYL ESTER (MAXOMEGATM EPA 96EE)(30 KG\/10 KG PER BOTTLE. USD 10500)","address":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N","city":"HYDERABAD","supplier":"BASF CORP","supplierCountry":"UNITED KINGDOM","foreign_port":"#N\/A","customer":"DR REDDY'S LABORATORIES","customerCountry":"INDIA","quantity":"30.00","actualQuantity":"30","unit":"KGS","unitRateFc":"350","totalValueFC":"12678.1","currency":"USD","unitRateINR":"31481.2","date":"27-Jan-2022","totalValueINR":"944435.32","totalValueInUsd":"12678.1","indian_port":"BANGALORE AIR","hs_no":"29163990","bill_no":"7250573","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"#N\/A","supplierAddress":"","customerAddress":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1643221800,"product":"ICOSAPENT ETHYL EICOSAPENTAENOIC ACID ETHYL ESTER (MAXOMEGATM EPA 96EE)(50 KG\/10 KG PER BOTTLE. USD 17500)","address":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N","city":"HYDERABAD","supplier":"BASF CORP","supplierCountry":"UNITED KINGDOM","foreign_port":"#N\/A","customer":"DR REDDY'S LABORATORIES","customerCountry":"INDIA","quantity":"50.00","actualQuantity":"50","unit":"KGS","unitRateFc":"350","totalValueFC":"21130.2","currency":"USD","unitRateINR":"31481.2","date":"27-Jan-2022","totalValueINR":"1574058.86","totalValueInUsd":"21130.2","indian_port":"BANGALORE AIR","hs_no":"29163990","bill_no":"7250573","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"#N\/A","supplierAddress":"","customerAddress":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1646418600,"product":"ICOSAPENT ETHYL (EICOSAPENTAENOIC ACID ETHYL ESTER) (MAXOMEGA TM EPA 96 EE )","address":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N","city":"HYDERABAD","supplier":"BASF CORP","supplierCountry":"GERMANY","foreign_port":"NA","customer":"DR REDDY'S LABORATORIES","customerCountry":"INDIA","quantity":"1.30","actualQuantity":"1.3","unit":"KGS","unitRateFc":"350","totalValueFC":"549.2","currency":"USD","unitRateINR":"32197","date":"05-Mar-2022","totalValueINR":"41856.13","totalValueInUsd":"549.2","indian_port":"HYDERABAD AIR","hs_no":"29161990","bill_no":"7747087","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1646418600,"product":"ICOSAPENT ETHYL (EICOSAPENTAENOIC ACID ETHYL ESTER) (MAXOMEGA TM EPA 96 EE)","address":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N","city":"HYDERABAD","supplier":"BASF CORP","supplierCountry":"GERMANY","foreign_port":"NA","customer":"DR REDDY'S LABORATORIES","customerCountry":"INDIA","quantity":"1.30","actualQuantity":"1.3","unit":"KGS","unitRateFc":"350","totalValueFC":"549.2","currency":"USD","unitRateINR":"32197","date":"05-Mar-2022","totalValueINR":"41856.13","totalValueInUsd":"549.2","indian_port":"HYDERABAD AIR","hs_no":"29161990","bill_no":"7747087","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1656181800,"product":"ICOSAPENT ETHYL","address":"407\/408 SHARDA CHAMBERS,NEW MARINE LINES","city":"MUMBAI,MAHARASHTRA","supplier":"AK MN BIOFARM COLTD","supplierCountry":"KOREA, REPUBLIC OF","foreign_port":"NA","customer":"BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LTD","customerCountry":"INDIA","quantity":"5.00","actualQuantity":"5","unit":"KGS","unitRateFc":"250","totalValueFC":"1265","currency":"USD","unitRateINR":"19737.5","date":"26-Jun-2022","totalValueINR":"98687.5","totalValueInUsd":"1265","indian_port":"BOMBAY AIR","hs_no":"29420090","bill_no":"9286278","productDescription":"API","marketType":"REGULATED MARKET","country":"KOREA,REPUBLIC OF","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"407\/408 SHARDA CHAMBERS,NEW MARINE LINES"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1659637800,"product":"ICOSAPENT ETHYL (EICOSAPENTAENOIC ACID ETHYL ESTER (MAXOMEGATM EPA 96EE))(100 KG\/10 KG PER BOTTLE. USD 35000)","address":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N","city":"HYDERABAD","supplier":"BASF CORP","supplierCountry":"UNITED KINGDOM","foreign_port":"NA","customer":"DR REDDY'S LABORATORIES","customerCountry":"INDIA","quantity":"100.00","actualQuantity":"100","unit":"KGS","unitRateFc":"350","totalValueFC":"42757.6","currency":"USD","unitRateINR":"34021","date":"05-Aug-2022","totalValueINR":"3402098.44","totalValueInUsd":"42757.6","indian_port":"BANGALORE AIR","hs_no":"29163990","bill_no":"9876859","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1672597800,"product":"ICOSAPENT ETHYL (EICOSAPENTAENOIC ACID ETHYL ESTER(MAXOMEGAEPA 96EE)","address":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N","city":"HYDERABAD","supplier":"BASF CORP","supplierCountry":"UNITED KINGDOM","foreign_port":"NA","customer":"DR REDDY'S LABORATORIES","customerCountry":"INDIA","quantity":"1.50","actualQuantity":"1.5","unit":"KGS","unitRateFc":"350","totalValueFC":"649.8","currency":"USD","unitRateINR":"35420","date":"02-Jan-2023","totalValueINR":"53129.97","totalValueInUsd":"649.8","indian_port":"BANGALORE AIR","hs_no":"29163990","bill_no":"4006633","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1673029800,"product":"ICOSAPENT ETHYL (MAX OMEGA EPA 96 EE)FOR TESTING PURPOSENO COMMERCIAL VALUE,VALUE FOR CUSTOMS PURPOSE ONLY)","address":"NO.18, GROUND FLOOR, DR. NAIR ROAD,T.NAGAR,","city":"CHENNAI.","supplier":"BASF CORP","supplierCountry":"UNITED KINGDOM","foreign_port":"NA","customer":"SOFTGEL HEALTHCARE PRIVATE LTD","customerCountry":"INDIA","quantity":"570.00","actualQuantity":"570","unit":"KGS","unitRateFc":"350","totalValueFC":"206478.9","currency":"USD","unitRateINR":"29616.8","date":"07-Jan-2023","totalValueINR":"16881600.75","totalValueInUsd":"206478.9","indian_port":"MADRAS AIR","hs_no":"29161990","bill_no":"4069167","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"NO.18, GROUND FLOOR, DR. NAIR ROAD,T.NAGAR,"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1680114600,"product":"EICOSAPENTAENOIC ACID","address":"H.NO.8-3-166\/7\/1, HETERO HOUSE, ERRAGADDA Contact No: 919396743330","city":"HYDERABAD","supplier":"JIANGSU GUOTAI GUOMIAN TRADING CO LTD","supplierCountry":"CHINA","foreign_port":"NA","customer":"HONOUR LAB LTD","customerCountry":"INDIA","quantity":"20.00","actualQuantity":"20","unit":"KGS","unitRateFc":"238","totalValueFC":"4843.9","currency":"USD","unitRateINR":"19920.6","date":"30-Mar-2023","totalValueINR":"398412","totalValueInUsd":"4843.9","indian_port":"MADRAS AIR","hs_no":"29339990","bill_no":"5294562","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"H.NO.8-3-166\/7\/1, HETERO HOUSE, ERRAGADDA Contact No: 919396743330"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1693247400,"product":"ICOSAPENT ETHYL J.P. CAS NO. 86227-47-6 DOCUMENT NO. BD080423E97D00E1330 DTD. 08.07.2023","address":"407\/408 SHARDA CHAMBERS,NEW MARINE LINES","city":"MUMBAI","supplier":"M S AK MN BIOFARM CO LTD","supplierCountry":"KOREA, REPUBLIC OF","foreign_port":"NA","customer":"BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LTD","customerCountry":"INDIA","quantity":"1330.00","actualQuantity":"1330","unit":"KGS","unitRateFc":"146","totalValueFC":"196634.1","currency":"USD","unitRateINR":"12124.5","date":"29-Aug-2023","totalValueINR":"16288443.32","totalValueInUsd":"196634.1","indian_port":"JNPT\/ NHAVA SHEVA SEA","hs_no":"29162090","bill_no":"0","productDescription":"API","marketType":"REGULATED MARKET","country":"SOUTH KOREA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"407\/408 SHARDA CHAMBERS,NEW MARINE LINES"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1696012200,"product":"EICOSAPENTAENOIC ACID","address":"8-3-166\/7\/1, HETERO HOUSE,","city":"HYDERABAD, AP.","supplier":"UNDISCLOSED","supplierCountry":"CHINA","foreign_port":"SHANGHAI","customer":"HONOUR LAB LTD","customerCountry":"INDIA","quantity":"25.00","actualQuantity":"25","unit":"KGS","unitRateFc":"223","totalValueFC":"5645","currency":"USD","unitRateINR":"18743.2","date":"30-Sep-2023","totalValueINR":"468579","totalValueInUsd":"5645","indian_port":"Madras Air","hs_no":"29161290","bill_no":"8084558","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI","supplierAddress":"N\/A","customerAddress":"8-3-166\/7\/1, HETERO HOUSE,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1707762600,"product":"ICOSAPENT ETHYL 97% (FOR LABORATORY RESEARCH)","address":"IRIS- 1004, KESAR GARDEN, PLOT NO.","city":"NAVI MUMBAI.","supplier":"KINOMEGA BIOPHARM INC","supplierCountry":"CHINA","foreign_port":"SHANGHAI","customer":"V ENSURE PHARMA TECHNOLOGIES PRIVATE LTD","customerCountry":"INDIA","quantity":"5.00","actualQuantity":"5","unit":"KGS","unitRateFc":"220","totalValueFC":"1112.9","currency":"USD","unitRateINR":"18469","date":"13-Feb-2024","totalValueINR":"92345","totalValueInUsd":"1112.9","indian_port":"Bombay Air","hs_no":"29159099","bill_no":"2120625","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI","supplierAddress":"No.161, South Yinghuashan Road, Shifang, Deyang City, Sichuan, China,618400 China","customerAddress":"IRIS- 1004, KESAR GARDEN, PLOT NO."},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1708453800,"product":"ETHYL ICOSAPENTATE OMEGA 3 - ORGANIC CHEMICAL","address":"NO S 26 BOMMASANDRA INDUSTRIAL ARE","city":"BANGALORE,KARNATAKA","supplier":"FINORGA SAS","supplierCountry":"FRANCE","foreign_port":"PARIS - CHARLES DE G","customer":"ALTHERA LABORATORIES INDIA PRIVATE LTD","customerCountry":"INDIA","quantity":"10.00","actualQuantity":"10","unit":"KGS","unitRateFc":"428","totalValueFC":"4676","currency":"EURO","unitRateINR":"38798.2","date":"21-Feb-2024","totalValueINR":"387982","totalValueInUsd":"4676","indian_port":"Bangalore Air","hs_no":"29161990","bill_no":"2240597","productDescription":"API","marketType":"REGULATED MARKET","country":"FRANCE","selfForZScoreResived":"Pharma Grade","supplierPort":"PARIS - CHARLES DE G","supplierAddress":"AVENUE DU LAC,F-64150, MOURENX,FRANCESDNF France","customerAddress":"NO S 26 BOMMASANDRA INDUSTRIAL ARE"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1708626600,"product":"ICOSAPENT ETHYL (FOR R&D PURPOSE ONLY)","address":"IRIS- 1004, KESAR GARDEN, PLOT NO.","city":"NAVI MUMBAI.","supplier":"FINORGA SAS","supplierCountry":"FRANCE","foreign_port":"PARIS - CHARLES DE G","customer":"V ENSURE PHARMA TECHNOLOGIES PRIVATE LTD","customerCountry":"INDIA","quantity":"5.00","actualQuantity":"5","unit":"KGS","unitRateFc":"448","totalValueFC":"2447.2","currency":"EURO","unitRateINR":"40611.2","date":"23-Feb-2024","totalValueINR":"203056","totalValueInUsd":"2447.2","indian_port":"Bombay Air","hs_no":"29161990","bill_no":"2273653","productDescription":"API","marketType":"REGULATED MARKET","country":"FRANCE","selfForZScoreResived":"Pharma Grade","supplierPort":"PARIS - CHARLES DE G","supplierAddress":"AVENUE DU LAC, F-64150 MOURENXSDNFSDNF France","customerAddress":"IRIS- 1004, KESAR GARDEN, PLOT NO."},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1731868200,"product":"ICOSAPENT ETHYL J.P (INV NO. BD111124E97D00E1520 DTD. 11.11.2024)","address":"407\/408,SHARDA CHAMBERS,","city":"MUMBAI, MAHARASHTRA.","supplier":"AK BIOPHARM CO LTD","supplierCountry":"KOREA, REPUBLIC OF","foreign_port":"SEOUL - INCHEON INT\\'","customer":"BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LTD","customerCountry":"INDIA","quantity":"1520.00","actualQuantity":"1520","unit":"KGS","unitRateFc":"113","totalValueFC":"173615.9","currency":"USD","unitRateINR":"9638.9","date":"18-Nov-2024","totalValueINR":"14651128","totalValueInUsd":"173615.9","indian_port":"Bombay Air","hs_no":"29162090","bill_no":"6733867","productDescription":"API","marketType":"REGULATED MARKET","country":"REPUBLIC OF KOREA","selfForZScoreResived":"Pharma Grade","supplierPort":"SEOUL - INCHEON INT\\'","supplierAddress":"81, SANGGAE-RO, NAM-GU UISAN 44787 REPLUBLIC OF KOREA KR","customerAddress":"407\/408,SHARDA CHAMBERS,"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1737743400,"product":"EICOSAPENTAENOIC ACID EICOSAPENTAENOIC ACID","address":"8-3-166\/7\/1, HETERO HOUSE,","city":"HYDERABAD, AP.","supplier":"JIANGSU GUOTAI GUOMIAN TRADING CO LTD","supplierCountry":"CHINA","foreign_port":"SHANGHAI","customer":"HONOUR LAB LTD","customerCountry":"INDIA","quantity":"30.00","actualQuantity":"30","unit":"KGS","unitRateFc":"235","totalValueFC":"7121.2","currency":"USD","unitRateINR":"20468.5","date":"25-Jan-2025","totalValueINR":"614055","totalValueInUsd":"7121.2","indian_port":"Madras Air","hs_no":"29161990","bill_no":"7989915","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI","supplierAddress":"19-21\/F GUOTAI BLDG.,RENMIN ROAD, ZHANGJIAGANG,JIANGSU, CHINA","customerAddress":"8-3-166\/7\/1, HETERO HOUSE,"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1740940200,"product":"ICOSAPENT ETHYL USP (CAS NO. 86227-47-6)","address":"3RD FLOOR, PLOT NO.2, MAITRIVIHAR,","city":"HYDERABAD, ANDHRA PRADESH","supplier":"FLAVINE NORTH AMERICA INC","supplierCountry":"CHINA","foreign_port":"BEIJING","customer":"APL HEALTHCARE LTD","customerCountry":"INDIA","quantity":"203.25","actualQuantity":"203.25","unit":"KGS","unitRateFc":"500","totalValueFC":"102953.6","currency":"USD","unitRateINR":"43875","date":"03-Mar-2025","totalValueINR":"8917593.75","totalValueInUsd":"102953.6","indian_port":"SEZ\/Mahaboobnagar","hs_no":"29161990","bill_no":"8665168","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"BEIJING","supplierAddress":"61 SOUTH PARAMUS ROAD SUITE 565 PARAMUS NEW JERSEY SDNF UNITED STATES","customerAddress":"3RD FLOOR, PLOT NO.2, MAITRIVIHAR,"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q2","strtotime":1751221800,"product":"MAXOMEGA # EPA 96 EE (ICOSAPENT ETHYL) 190KG STEEL DRUMS ICOSAPENT ETHYL","address":"H.NO. 8-2-337,BESIDE TV9 OFFICE","city":"HYDERABAD ANDHRA PRADESH","supplier":"BASF PHARMA (CALLANISH) LTD","supplierCountry":"UNITED KINGDOM","foreign_port":"GLASGOW","customer":"DR REDDY'S LABORATORIES","customerCountry":"INDIA","quantity":"760.00","actualQuantity":"760","unit":"KGS","unitRateFc":"98.6","totalValueFC":"76455.1","currency":"USD","unitRateINR":"8644","date":"30-Jun-2025","totalValueINR":"6569440","totalValueInUsd":"76455.1","indian_port":"Hyderabad Air","hs_no":"29161990","bill_no":"2958600","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"GLASGOW","supplierAddress":"2 STOCKPORT EXCHANGE RAILWAY ROAD S TOCKPORT SK1 3GG, UNITED KINGDOM SDNF United Kingdom","customerAddress":"H.NO. 8-2-337,BESIDE TV9 OFFICE"}]
27-Jan-2022
30-Jun-2025
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API/FDF Prices: Book a Demo to explore the features and consider upgrading later

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Drugs in Development

read-more
read-more

Details:

Dr Reddy's Laboratories announced the launch of Icosapent Ethyl Capsules, used to reduce triglyceride (TG) levels in adult patients, in the US market. Dr Reddy's Icosapent Ethyl is available in 1 gram capsules in bottle count size of 120's count.


Lead Product(s): Icosapent Ethyl,Inapplicable

Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Undisclosed

Study Phase: Approved FDFProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable June 22, 2021

Dr Reddy Company Banner

01

Lead Product(s) : Icosapent Ethyl,Inapplicable

Therapeutic Area : Cardiology/Vascular Diseases

Highest Development Status : Approved FDF

Partner/Sponsor/Collaborator : Undisclosed

Deal Size : Inapplicable

Deal Type : Inapplicable

Details : Dr Reddy's Laboratories announced the launch of Icosapent Ethyl Capsules, used to reduce triglyceride (TG) levels in adult patients, in the US market. Dr Reddy's Icosapent Ethyl is available in 1 gram capsules in bottle count size of 120's count.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

June 22, 2021

Dr Reddy Company Banner

Details:

Vascepa-Generic (icosapent ethyl) is an ethyl ester of eicosapentaenoic acid (EPA) which is indicated to reduce the risk of myocardial infarction, stroke, coronary revascularization, and unstable angina.


Lead Product(s): Icosapent Ethyl,Inapplicable

Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Vascepa-Generic

Study Phase: Approved FDFProduct Type: Miscellaneous

Sponsor: Amneal Pharmaceuticals

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable December 02, 2023

Strides Pharma Science

02

Lead Product(s) : Icosapent Ethyl,Inapplicable

Therapeutic Area : Cardiology/Vascular Diseases

Highest Development Status : Approved FDF

Partner/Sponsor/Collaborator : Amneal Pharmaceuticals

Deal Size : Inapplicable

Deal Type : Inapplicable

Details : Vascepa-Generic (icosapent ethyl) is an ethyl ester of eicosapentaenoic acid (EPA) which is indicated to reduce the risk of myocardial infarction, stroke, coronary revascularization, and unstable angina.

Product Name : Vascepa-Generic

Product Type : Miscellaneous

Upfront Cash : Inapplicable

December 02, 2023

Strides Pharma Science

Details:

Under the agreement, Amneal in-licensed Icosapent ethyl acid soft gel capsules, a product referencing Vascepa and an ethyl ester of eicosapentaenoic acid that is indicated as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia.


Lead Product(s): Icosapent Ethyl,Inapplicable

Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Vascepa-Generic

Study Phase: Approved FDFProduct Type: Miscellaneous

Sponsor: Amneal Pharmaceuticals

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Licensing Agreement December 01, 2023

Strides Pharma Science

03

Lead Product(s) : Icosapent Ethyl,Inapplicable

Therapeutic Area : Cardiology/Vascular Diseases

Highest Development Status : Approved FDF

Partner/Sponsor/Collaborator : Amneal Pharmaceuticals

Deal Size : Undisclosed

Deal Type : Licensing Agreement

Details : Under the agreement, Amneal in-licensed Icosapent ethyl acid soft gel capsules, a product referencing Vascepa and an ethyl ester of eicosapentaenoic acid that is indicated as an adjunct to diet to reduce triglyceride levels in adult patients with severe ...

Product Name : Vascepa-Generic

Product Type : Miscellaneous

Upfront Cash : Undisclosed

December 01, 2023

Strides Pharma Science

Details:

Icosapent ethyl capsules is an ethyl ester of eicosapentaenoic acid (EPA), which is indicated for the treatment of to reduce the risk of myocardial infarction, stroke, coronary revascularization, and unstable angina in adult patients with elevated triglyceride.


Lead Product(s): Icosapent Ethyl,Inapplicable

Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Vascepa-Generic

Study Phase: Approved FDFProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable October 03, 2023

Strides Pharma Science

04

Lead Product(s) : Icosapent Ethyl,Inapplicable

Therapeutic Area : Cardiology/Vascular Diseases

Highest Development Status : Approved FDF

Partner/Sponsor/Collaborator : Undisclosed

Deal Size : Inapplicable

Deal Type : Inapplicable

Details : Icosapent ethyl capsules is an ethyl ester of eicosapentaenoic acid (EPA), which is indicated for the treatment of to reduce the risk of myocardial infarction, stroke, coronary revascularization, and unstable angina in adult patients with elevated trigly...

Product Name : Vascepa-Generic

Product Type : Miscellaneous

Upfront Cash : Inapplicable

October 03, 2023

Strides Pharma Science

Details:

Under the licensing agreement, Recordati will be responsible for commercialization of Vazkepa (Icosapent Ethyl) in Europe. It is being indicated to reduce the risk of myocardial infarction, stroke.


Lead Product(s): Icosapent Ethyl,Inapplicable

Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Vascepa

Study Phase: Approved FDFProduct Type: Miscellaneous

Sponsor: Recordati

Deal Size: $175.0 million Upfront Cash: $25.0 million

Deal Type: Licensing Agreement June 24, 2025

blank

05

Amarin

Ireland
arrow
DDL Conference
Not Confirmed

Amarin

Ireland
arrow
DDL Conference
Not Confirmed

Details : Under the licensing agreement, Recordati will be responsible for commercialization of Vazkepa (Icosapent Ethyl) in Europe. It is being indicated to reduce the risk of myocardial infarction, stroke.

Product Name : Vascepa

Product Type : Miscellaneous

Upfront Cash : $25.0 million

June 24, 2025

blank
  • Development Update

Details:

Eicosapentaenoic Acid is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Hypertriglyceridemia.


Lead Product(s): Icosapent Ethyl,Hydroxytyrosol

Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Undisclosed

Study Phase: UndisclosedProduct Type: Miscellaneous

Sponsor: Beps Holding GmbH | Olivenova Health Sl

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable May 28, 2025

blank

06

National Research Council, Spain

Country
arrow
Saudi International Expo
Not Confirmed

National Research Council, Spain

Country
arrow
Saudi International Expo
Not Confirmed

Details : Eicosapentaenoic Acid is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Hypertriglyceridemia.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

May 28, 2025

blank

Details:

Fish Oil is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.


Lead Product(s): Fish Oil,Icosapent Ethyl,L-5- Methyltetrahydrofolate

Therapeutic Area: Undisclosed Brand Name: Undisclosed

Study Phase: UndisclosedProduct Type: Dietary Supplement

Sponsor: Glogen Clinical Research Pvt. Ltd

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable January 06, 2025

blank

07

Saudi International Expo
Not Confirmed
Saudi International Expo
Not Confirmed

Lead Product(s) : Fish Oil,Icosapent Ethyl,L-5- Methyltetrahydrofolate

Therapeutic Area : Undisclosed

Highest Development Status : Undisclosed

Partner/Sponsor/Collaborator : Glogen Clinical Research Pvt. Ltd

Deal Size : Inapplicable

Deal Type : Inapplicable

Details : Fish Oil is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.

Product Name : Undisclosed

Product Type : Dietary Supplement

Upfront Cash : Inapplicable

January 06, 2025

blank

Details:

Vascepa (icosapent ethyl) is an ethyl ester of eicosapentaenoic acid (EPA) which is indicated to reduce the risk of myocardial infarction, stroke, coronary revascularization, and unstable angina.


Lead Product(s): Icosapent Ethyl,Inapplicable

Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Vascepa

Study Phase: Approved FDFProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable July 08, 2024

blank

08

Edding Pharm

China
arrow
Saudi International Expo
Not Confirmed

Edding Pharm

China
arrow
Saudi International Expo
Not Confirmed

Details : Vascepa (icosapent ethyl) is an ethyl ester of eicosapentaenoic acid (EPA) which is indicated to reduce the risk of myocardial infarction, stroke, coronary revascularization, and unstable angina.

Product Name : Vascepa

Product Type : Miscellaneous

Upfront Cash : Inapplicable

July 08, 2024

blank

Details:

Under the terms of the agreement, Vianex will be the sole and exclusive distributor of Vazkepa (icosapent ethyl). it is an approved product indicated for the treatment of cardiovascular diseases.


Lead Product(s): Icosapent Ethyl,Inapplicable

Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Vazkepa

Study Phase: Approved FDFProduct Type: Miscellaneous

Sponsor: Vianex S.A

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Agreement May 28, 2024

blank

09

Amarin

Ireland
arrow
DDL Conference
Not Confirmed

Amarin

Ireland
arrow
DDL Conference
Not Confirmed

Details : Under the terms of the agreement, Vianex will be the sole and exclusive distributor of Vazkepa (icosapent ethyl). it is an approved product indicated for the treatment of cardiovascular diseases.

Product Name : Vazkepa

Product Type : Miscellaneous

Upfront Cash : Undisclosed

May 28, 2024

blank

Details:

Vazkepa (icosapent ethyl) is an ethyl ester of eicosapentaenoic acid that reduces synthesis and enhances clearance of triglycerides that is used to treat patients with severe hypertriglyceridemia.


Lead Product(s): Icosapent Ethyl,Inapplicable

Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Vazkepa

Study Phase: Approved FDFProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable August 09, 2023

blank

10

Amarin

Ireland
arrow
DDL Conference
Not Confirmed

Amarin

Ireland
arrow
DDL Conference
Not Confirmed

Details : Vazkepa (icosapent ethyl) is an ethyl ester of eicosapentaenoic acid that reduces synthesis and enhances clearance of triglycerides that is used to treat patients with severe hypertriglyceridemia.

Product Name : Vazkepa

Product Type : Miscellaneous

Upfront Cash : Inapplicable

August 09, 2023

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Parenteral

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Fillers, Diluents & Binders

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Solubilizers

read-more
read-more

Taste Masking

read-more
read-more

Topical

read-more
read-more

Coating Systems & Additives

read-more
read-more

Empty Capsules

read-more
read-more

Emulsifying Agents

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

Coloring Agents

read-more
read-more

Co-Processed Excipients

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Direct Compression

read-more
read-more

Lubricants & Glidants

read-more
read-more

API Stability Enhancers

read-more
read-more

Rheology Modifiers

read-more
read-more

Controlled & Modified Release

read-more
read-more

Soft Gelatin

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Looking for 10417-94-4 / Icosapent Ethyl API manufacturers, exporters & distributors?

Icosapent Ethyl manufacturers, exporters & distributors 1

93

PharmaCompass offers a list of Icosapent Ethyl API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Icosapent Ethyl manufacturer or Icosapent Ethyl supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Icosapent Ethyl manufacturer or Icosapent Ethyl supplier.

PharmaCompass also assists you with knowing the Icosapent Ethyl API Price utilized in the formulation of products. Icosapent Ethyl API Price is not always fixed or binding as the Icosapent Ethyl Price is obtained through a variety of data sources. The Icosapent Ethyl Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Icosapent Ethyl

Synonyms

Timnodonic acid, Icosapent, 10417-94-4, Icosapentaenoic acid, Epa, Cis-5,8,11,14,17-eicosapentaenoic acid

Cas Number

10417-94-4

Unique Ingredient Identifier (UNII)

AAN7QOV9EA

About Icosapent Ethyl

Important polyunsaturated fatty acid found in fish oils. It serves as the precursor for the prostaglandin-3 and thromboxane-3 families. A diet rich in eicosapentaenoic acid lowers serum lipid concentration, reduces incidence of cardiovascular disorders, prevents platelet aggregation, and inhibits arachidonic acid conversion into the thromboxane-2 and prostaglandin-2 families.

Icosapent Ethyl Manufacturers

A Icosapent Ethyl manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Icosapent Ethyl, including repackagers and relabelers. The FDA regulates Icosapent Ethyl manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Icosapent Ethyl API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Icosapent Ethyl manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Icosapent Ethyl Suppliers

A Icosapent Ethyl supplier is an individual or a company that provides Icosapent Ethyl active pharmaceutical ingredient (API) or Icosapent Ethyl finished formulations upon request. The Icosapent Ethyl suppliers may include Icosapent Ethyl API manufacturers, exporters, distributors and traders.

click here to find a list of Icosapent Ethyl suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Icosapent Ethyl USDMF

A Icosapent Ethyl DMF (Drug Master File) is a document detailing the whole manufacturing process of Icosapent Ethyl active pharmaceutical ingredient (API) in detail. Different forms of Icosapent Ethyl DMFs exist exist since differing nations have different regulations, such as Icosapent Ethyl USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Icosapent Ethyl DMF submitted to regulatory agencies in the US is known as a USDMF. Icosapent Ethyl USDMF includes data on Icosapent Ethyl's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Icosapent Ethyl USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Icosapent Ethyl suppliers with USDMF on PharmaCompass.

Icosapent Ethyl JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The Icosapent Ethyl Drug Master File in Japan (Icosapent Ethyl JDMF) empowers Icosapent Ethyl API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the Icosapent Ethyl JDMF during the approval evaluation for pharmaceutical products. At the time of Icosapent Ethyl JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of Icosapent Ethyl suppliers with JDMF on PharmaCompass.

Icosapent Ethyl KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Icosapent Ethyl Drug Master File in Korea (Icosapent Ethyl KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Icosapent Ethyl. The MFDS reviews the Icosapent Ethyl KDMF as part of the drug registration process and uses the information provided in the Icosapent Ethyl KDMF to evaluate the safety and efficacy of the drug.

After submitting a Icosapent Ethyl KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Icosapent Ethyl API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Icosapent Ethyl suppliers with KDMF on PharmaCompass.

Icosapent Ethyl GMP

Icosapent Ethyl Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Icosapent Ethyl GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Icosapent Ethyl GMP manufacturer or Icosapent Ethyl GMP API supplier for your needs.

Icosapent Ethyl CoA

A Icosapent Ethyl CoA (Certificate of Analysis) is a formal document that attests to Icosapent Ethyl's compliance with Icosapent Ethyl specifications and serves as a tool for batch-level quality control.

Icosapent Ethyl CoA mostly includes findings from lab analyses of a specific batch. For each Icosapent Ethyl CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Icosapent Ethyl may be tested according to a variety of international standards, such as European Pharmacopoeia (Icosapent Ethyl EP), Icosapent Ethyl JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Icosapent Ethyl USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty